Navigation Links
Rensselaer Polytechnic Institute professor Peter M. Tessier named Pew Scholar
Date:6/17/2010

Troy, N.Y. Peter M. Tessier, assistant professor of chemical and biological engineering at Rensselaer Polytechnic Institute, has been named a 2010 Pew Scholar in the Biomedical Sciences by the Pew Charitable Trusts.

The distinction includes an award of $240,000 over four years and inclusion into a select community of scientists that includes three Nobel Prize winners, three MacArthur Fellows, and two recipients of the Albert Lasker Medical Research Award, according to the Pew Charitable Trusts.

"We congratulate Dr. Tessier for being selected as a Pew Scholar in Biomedical Sciences, an honor reserved for the most promising young faculty in the biomedical field," said David Rosowsky, dean of the School of Engineering at Rensselaer. "We are extremely proud of Peter for being named a Pew Scholar as well as his recent CAREER Award from the National Science Foundation and we look forward to his continued development as a leading scholar and researcher. Dr. Tessier's recent recognitions are further evidence of the very high caliber of faculty we are attracting to Rensselaer."

Tessier joined the Rensselaer faculty in 2007 following a postdoctoral fellowship at the Massachusetts Institute of Technology's Whitehead Institute for Biomedical Research. He received his bachelor's degree in chemical engineering from the University of Maine, and went on to earn his doctoral degree in chemical engineering from the University of Delaware.

Tessier is investigating fundamental aspects of misfolding and clumping of three classes of proteins, long strings of molecules that participate in virtually every cellular process. Proteins fold into complex, three-dimensional structures, which is required for their proper function. Defects in the folding process can occur, which creates toxic protein clumps that are the basis of disorders ranging from Alzheimer's disease to glaucoma.

Tessier's immediate goal is to understand how the incorrect processing of proteins can be prevented, reversed, or redirected. His long-term objective is to develop new therapies to treat diseases related to toxic protein aggregation.

The Pew Scholars program enables scientists to take calculated risks, expand their research, and explore unanticipated leads. According to Pew, the program now in its 25th year has invested more than $125 million to fund nearly 500 scholars. Many of the nation's best early-career scientistsworking in all areas of physical and life sciences related to biomedical researchapply to the rigorously competitive program. Applicants are nominated by one of 155 invited institutions and demonstrate excellence and innovation in their research.

"Twenty-five years ago, the Pew Charitable Trusts identified a tremendous opportunity to impact the world of science by supporting the most promising young investigators and encouraging them to pursue their best ideas without restrictions," said Rebecca W. Rimel, president and CEO of the Pew Charitable Trusts. "Motivating scientists at this point in their careers is essential to advancing discovery and innovation, and Pew is honored to continue its commitment to this cadre of high-quality researchers."

Earlier this year, Tessier was also awarded a five-year, $411,872 Faculty Early Career Development Award (CAREER) from the National Science Foundation (NSF) to further his research into protein thermodynamics and aggregation.


'/>"/>

Contact: Mary Martialay
martialay@earthlink.net
518-276-2176
Rensselaer Polytechnic Institute
Source:Eurekalert

Related biology news :

1. Rensselaer Polytechnic Institute professor Patrick Underhill receives NSF CAREER award
2. Rensselaer Polytechnic Institute wins $2.45 million grant to support stem cell research
3. Rensselaer researchers to send bacteria into orbit aboard space shuttle Atlantis
4. Rensselaer leads effort to replace 1 of the most widely used drugs in American hospitals
5. Rensselaer receives more than $2 million from New York State to fund stem cell research
6. Trustee makes donation to start new solar energy research center at Rensselaer
7. Deadly dose: Rensselaer heparin expert helps uncover source of lethal contamination
8. Gladstone and Institute for Systems Biology collaborate on Huntingtons disease
9. National Eye Institute hosts Translational Research and Vision Symposium
10. University of Washington institute to get as much as $100 million to study atmosphere, ocean
11. Norwegian Institute of Public Health receives $100,000 Grand Challenges Explorations grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:4/14/2016)... , April 14, 2016 ... Malware Detection, today announced the appointment of Eyal ... new role. Goldwerger,s leadership appointment comes at ... heels of the deployment of its platform at several ... biometric technology, which discerns unique cognitive and physiological factors, ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
(Date:6/23/2016)... SILVER SPRING, Md. , June 23, 2016 ... evidence collected from the crime scene to track the criminal ... sick, and the U.S. Food and Drug Administration (FDA) uses ... Sound far-fetched? It,s not. ... whole genome sequencing to support investigations of foodborne illnesses. Put ...
(Date:6/23/2016)...   EpiBiome , a precision microbiome engineering company, ... financing from Silicon Valley Bank (SVB). The financing will ... its drug development efforts, as well as purchase additional ... has been an incredible strategic partner to us – ... would provide," said Dr. Aeron Tynes Hammack , ...
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a company ... to the medical community, has closed its Series A ... Nunez . "We have received a commitment ... capital we need to meet our current goals," stated ... us the runway to complete validation on the current ...
Breaking Biology Technology: